What Boehringer Ingelheim Pharmaceuticals, Inc. pays H-1B Clinical Data Scientists

Boehringer Ingelheim Pharmaceuticals, Inc. filed 10 certified H-1B LCAs for Clinical Data Scientist roles in FY2025-FY2026. In FY2026 (October to June), the middle half of its 6 filings stated $148,748 to $164,223 a year, with a median of $157,903.

Median, FY2026 so far$157,903
Middle half$148,748 to $164,223
Certified LCAs, FY2025-FY202610

By fiscal year

YearLCAsMedianMiddle halfLowest to highestPrevailing wage
FY2026 so far6$157,903$148,748 to $164,223$145,370 to $176,001$110,344
FY20254$142,085$140,844 to $145,614$137,405 to $155,920$137,405

Prevailing wage is the median of the DOL prevailing wage on the same filings: the floor the law sets for that job and place.

By prevailing-wage level

LevelLCAsMedianMiddle half
Level II (qualified)3$141,990too few
Level III (experienced)5$155,920$145,800 to $157,590
Level IV (fully competent)2$171,113too few

Level I is entry and Level IV is fully competent, as the employer classified the position. Seniority words in the job title are folded into one title here; the level is where seniority shows.

By worksite

WorksiteLCAsMedianLowest to highest
Ridgefield, CT7$157,590$145,370 to $176,001

Titles grouped here

Filed as Biostatisticians (SOC 15-2041).

Applying to Boehringer Ingelheim Pharmaceuticals, Inc.?

Nyanza puts these filings next to any Clinical Data Scientist posting you check, so you know what the employer has stated before the first call.

Other titles at Boehringer Ingelheim Pharmaceuticals, Inc.